Anti-VEGF

CLN-0046: Treatment of AMD Subjects With OTX-TKI

Study to Test the Safety and Tolerability of PF-07062119 in Patients With Selected Advanced or Metastatic Gastrointestinal Tumors.

Safety and Tolerability Study of Suprachoroidal Injection of CLS-AX Following Anti-VEGF Therapy in Neovascular AMD

X-82 to Treat Age-related Macular Degeneration

BITS-TO-HCC Study: HAIC+Iparomlimab/Tuvonralimab + Bevacizumab + SBRT for BCLC-C HCC With PVTT and/or Oligometastases

A Retrospective Study of Anti-Vascular Endothelial Growth Factor (VEGF) Injections for Retinal Vein Occlusion or Diabetic Macular Edema

Anti-VEGF Instead of Intraoperative PRP in Proliferative Diabetic Retinopathy

Anti-VEGF Instead of Intraoperative Fan-shaped Photocoagulation in BRVO Combined With Vitreous Hemorrhage

Anti-VEGF Therapy for Subfoveal Hemorrhage in Patients With Neovascular Age-Related Macular Degeneration

Influence of Systemic Parameters in Diabetic Macular Edema - LIPSIA Study

Effects of Anti-VEGF Targeted Drugs on Patients' Blood Pressure and Endothelial Function

A Study on the Treatment Strategy of NVG Secondary to PDR

Seven-year Outcomes Following Intensive Anti-VEGF Therapy in Wet AMD

Efficacy Analysis of Anti-VEGF Drugs Combined With Micropulse Laser in the Treatment of Diabetic Macular Edema

Anti-PD-1/PD-L1 Antibodies Plus Anti-VEGF Antibody Treatment in Patients With Advanced-Stage HCC